LT2-11299-93251
4 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 940 / CA
- Registered
- 2022-11-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-15
Dose 1 — Pfizer-BioNTech
-
2021-05-17
Dose 2 — Pfizer-BioNTech
-
2021-12-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-07
Dose 4 — Moderna
-
2022-11-08
Registered in v-safe
-
2022-11-08
Survey response — day 28, dose 4MedDRA: Pain, Pyrexia — Feeling: Poor · Be unable to work or attend schoolFree text: Mild fever and bodyacheMedDRA releases: 2024-11 · check-in free text available
- 2022-11-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Pfizer-BioNTech | No |
| 2 | 2021-05-17 | Pfizer-BioNTech | No |
| 3 | 2021-12-14 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-07 | Moderna | No |
Free text
Release 12 — day 28, dose 4
Symptoms: Mild fever and bodyache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release